The pump that saves hearts: Heart failure is one of the most common causes of death, and the number of lives affected continue to increase. The heart surgeon, Stephen Wildhirt, developed a novel implant that could prolong these lives.
This article can be viewed as a PDF document here. here. It first appeared in the issue 44/2019 on 26.10.2019 of the FOCUS news magazine. The article is available in German only.
AdjuCor’s Innovative Extravascular, Biventricular Cardiac Support Technology
What sets AdjuCor’ patented technology apart from the other LVADs currently available on the market, is its unique non-blood-contacting solution, its ability to support both ventricles, and its innovative patient-specific design. It is implanted by a heart team (cardiologist and cardiac surgeon) around the heart within a few minutes on the beating heart without sutures. It completely avoids blood contact and thereby any blood-related complications including strokes and bleeding – an invaluable advantage that cannot be over-stated. The energy transferred to the heart may be adjusted to each patient’s need. It thereby dramatically enhances the care of patients with heart failure and improves their quality of life.
AdjuCor was founded as GmbH in 2012 by the Cardiothoracic Surgeon Stephen Wildhirt and is funded by private investors, the European Union, as well as German and Bavarian entities. The company employs over thirty experts in all fields required and has received over 13 million euros of financing.
Contact: pr@adjucor.com